Guidant (GDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: cardiologist to be who wrote (78)	1/7/1998 9:31:00 PM
From: JMS	Read Replies (1) of 235

GDT will be OK on Feb. 3rd, the stent is supposedly way over 50%, things are good. My only real concern is the multiple that the market will give to GDT over the next couple of years-a multiple of 60 may be a bit much. Nonetheless, if they hit .50 or so on the 3rd, project that out at double digit growth, weaker margins(AVEI) and slap a 40-50 multiple on it......... They won't buy AVEI because they believe their stent is better. ACS/GDT are headed in the right direction. EVTI will propel the stock price in the next couple of years, if they pan out.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next